180 Degree Capital Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

180 Degree Capital hat ein Gesamteigenkapital von $50.2M und eine Gesamtverschuldung von $0.0, was einen Verschuldungsgrad von 0% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen $51.2M bzw. $952.8K.

Wichtige Informationen

Verhältnis von Schulden zu Eigenkapital

US$0

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	US$282.17k
Eigenkapital	US$45.04m
Gesamtverbindlichkeiten	US$934.36k
Gesamtvermögen	US$45.98m

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Introducing 180 Degree Capital (NASDAQ:TURN), A Stock That Climbed 33% In The Last Five Years

Feb 24

180 Degree Capital announces reverse stock split

Jan 04

180 Degree Capital initiates repurchases & 1-for-3 reverse stock split

Dec 21

180 Degree Capital reports Q3 results

Nov 18

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: TURNDie kurzfristigen Aktiva des Unternehmens ($980.4K) übersteigen seine kurzfristigen Passiva ($289.4K).

Langfristige Verbindlichkeiten: TURNDie kurzfristigen Vermögenswerte des Unternehmens ($412.9K) decken seine langfristigen Verbindlichkeiten ($629.1K) nicht.

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: TURN ist schuldenfrei.

Schulden abbauen: TURN hatte vor 5 Jahren keine Schulden.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: TURN hat auf der Grundlage seines derzeitigen freier Cashflows weniger als ein Jahr Liquiditätsspielraum.

Vorhersage Cash Runway: TURN hat weniger als ein Jahr Liquiditätsreserven, wenn der freie Cashflow weiterhin mit den historischen Raten von 34.9% pro Jahr abnimmt

180 Degree Capital Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

180 Degree Capital Q2 2024 Shareholder Letter

180 Degree Capital Corp. to Report Q2, 2024 Results on Aug 19, 2024

180 Degree Capital Q1 2024 Shareholder Letter

Chairman recently bought US$81k worth of stock

180 Degree Capital Corp. to Report Q1, 2024 Results on May 13, 2024

180 Degree Capital Corp., Annual General Meeting, Apr 15, 2024

180 Degree Capital Corp. to Report Q4, 2023 Results on Feb 20, 2024

180 Degree Capital Corp. to Report Q3, 2023 Results on Nov 13, 2023

Insufficient new directors

VP & Head of Fund Development recently bought US$175k worth of stock

Chairman recently bought US$212k worth of stock

Chairman recently bought US$111k worth of stock

Chairman recently bought US$54k worth of stock

Chairman recently bought US$54k worth of stock

VP & Head of Fund Development recently bought US$264k worth of stock

180 Degree Capital Corp. to Report Q3, 2022 Results on Nov 07, 2022

180 Degree Capital net asset value projected to drop in Q3

Now 20% undervalued after recent price drop

Chairman recently bought US$60k worth of stock

180 Degree Capital GAAP EPS of $8.35

180 Degree Capital Corp. to Report Q2, 2022 Results on Aug 08, 2022

180 Degree Capital estimates Q2 NAV to decline

180 Degree Capital Corp. to Report Q1, 2022 Results on May 11, 2022

Valo Health, Inc. acquired TARA Biosystems, Inc. from 180 Degree Capital Corp. (NasdaqGM:TURN), Alexandria Venture Investments, LLC, Mérieux Equity Partners SAS, LifeForce Capital, DEFTA Partners, New York City Investment Fund Manager, Inc. and others.

180 Degree Capital Corp., Annual General Meeting, Apr 20, 2022

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

180 Degree Capital Corp. to Report Q4, 2021 Results on Feb 24, 2022

Chairman recently bought US$85k worth of stock

Chairman recently bought US$65k worth of stock

Chairman recently bought US$64k worth of stock

Chairman recently bought US$150k worth of stock

First half 2021 earnings released: EPS US$1.40 (vs US$1.09 loss in 1H 2020)

Chairman recently bought US$67k worth of stock

Zymergen Inc. (NasdaqGS:ZY) acquired Lodo Therapeutics Corp. from Accelerator Life Science Partners I, managed by Accelerator Life Science Partners and others.

Chairman recently bought US$146k worth of stock

180 Degree Capital Corp., Annual General Meeting, Apr 20, 2021

Introducing 180 Degree Capital (NASDAQ:TURN), A Stock That Climbed 33% In The Last Five Years

Full year 2020 earnings released: EPS US$0.10 (vs US$1.27 in FY 2019)

New 90-day high: US$7.35

180 Degree Capital Corp. to Report Q4, 2020 Results on Feb 22, 2021

New 90-day high: US$6.90

New 90-day high: US$6.67

180 Degree Capital announces reverse stock split

Chairman recently bought US$150k worth of stock

New 90-day high: US$2.15

180 Degree Capital initiates repurchases & 1-for-3 reverse stock split

New 90-day high: US$2.03

180 Degree Capital reports Q3 results

180 Degree Capital Corp. to Report Q3, 2020 Results on Nov 18, 2020

New 90-day low: US$1.71

Synacor, Inc. (NasdaqGM:SYNC) entered into a merger agreement to acquire Qumu Corporation (NasdaqCM:QUMU) from 180 Degree Capital Corp. (NasdaqGM:TURN), Harbert Discovery Fund, LP, managed by Harbert Fund Advisors Inc. and others for $33.5 million in a merger of equals transaction.

An unknown buyer acquired Petra Pharma Corporation from 180 Degree Capital Corp. (NasdaqGM:TURN).

180 Degree Capital Corp. to Report Q2, 2020 Results on Aug 10, 2020

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Liquiditätsreserve-Analyse

Entdecken Sie finanziell stabile Unternehmen